26
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Ileocolonoscopic and Histologic Studies of Korean Patients with Ankylosing Spondylitis

, , , , , , & show all
Pages 473-476 | Received 02 Apr 1997, Accepted 28 Jul 1997, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eva Klingberg, Hans Carlsten, Elisabet Hilme, Martin Hedberg & Helena Forsblad-d'Elia. (2012) Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum. Scandinavian Journal of Gastroenterology 47:4, pages 435-444.
Read now

Articles from other publishers (13)

Einat Savin, Niv Ben-Shabat, Asaf Levartovsky, Adi Lahat, Mahmud Omar, Omer Gendelman, Merav Lidar, Abdulla Watad, Shomron Ben-Horin, Uri Kopylov & Kassem Sharif. (2023) Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center. Journal of Clinical Medicine 12:22, pages 7151.
Crossref
Alfred Yu Ting Chia, Gladys Wei Xin Ang, Anita Sook Yee Chan, Webber Chan, Timothy Kit Yeong Chong & Ying Ying Leung. (2021) Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis. Frontiers in Medicine 8.
Crossref
Marine Fauny, Ferdinando D’Amico, Stefanos Bonovas, Patrick Netter, Silvio Danese, Damien Loeuille & Laurent Peyrin-Biroulet. (2020) Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review. Journal of Crohn's and Colitis 14:5, pages 688-693.
Crossref
Caroline Di Jiang & Tim Raine. (2020) IBD considerations in spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2093941.
Crossref
Heleen Cypers, S. Louis BridgesJr.Jr. & Dirk Elewaut. 2018. The Microbiome in Rheumatic Diseases and Infection. The Microbiome in Rheumatic Diseases and Infection 201 220 .
Eva Klingberg, Hans Strid, Arne Ståhl, Anna Deminger, Hans Carlsten, Lena Öhman & Helena Forsblad-d’Elia. (2017) A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis. Arthritis Research & Therapy 19:1.
Crossref
Soo Min Ahn, Yong-Gil Kim, Seung-Hyeon Bae, Doo-Ho Lim, Seokchan Hong, Sang Hyoung Park, Chang-Keun Lee & Bin Yoo. (2017) Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study. The Korean Journal of Internal Medicine 32:5, pages 916-922.
Crossref
Simon Stebbings, Katey Jenks, Gareth J. Treharne, José A. García, Michael Schultz, John Highton & Sharon Dudley-Brown. (2012) Validation of the Dudley Inflammatory Bowel Symptom Questionnaire for the assessment of bowel symptoms in axial SpA: prevalence of clinically relevant bowel symptoms and association with disease activity. Rheumatology 51:5, pages 858-865.
Crossref
Gulen Hascelik, Bengi Oz, Nese Olmez, Asuman Memis, Gazi Yoruk, Belkıs Unsal & Nese Ekinci. (2008) Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis. Rheumatology International 29:7, pages 755-758.
Crossref
Hwee Siew Howe, Like Zhao, Yeong Wook Song, Lauren Springer, John Edmonds, Jieruo Gu & David TY Yu. (2007) Seronegative Spondyloarthropathy – Studies from the Asia Pacific Region. Annals of the Academy of Medicine, Singapore 36:2, pages 135-141.
Crossref
Simon Smale, Ravinder S. Natt, Timothy R. Orchard, Anthony S. Russell & Ingvar Bjarnason. (2001) Inflammatory bowel disease and spondylarthropathy. Arthritis & Rheumatism 44:12, pages 2728-2736.
Crossref
Simon Smale, Jeremy Tibble, Gudmundur Sigthorsson & Ingvar Bjarnason. (2001) Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Practice & Research Clinical Gastroenterology 15:5, pages 723-738.
Crossref
Filip De Keyser, Dirk Elewaut, Martine De Vos, Kurt De Vlam, Claude Cuvelier, Herman Mielants & Eric M. Veys. (1998) BOWEL INFLAMMATION AND THE SPONDYLOARTHROPATHIES. Rheumatic Disease Clinics of North America 24:4, pages 785-813.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.